Eurofarma Biosimilars Deal Broadens Access To Latin America For Henlius
Chinese Firm’s Bevacizumab, Rituximab And Trastuzumab Included In $50m Deal
• By David Wallace
Henlius will broaden access to markets in Latin America through the alliance with Brazil’s Eurofarma • Source: Shutterstock 
